Clinical applications of tumor suppressor genes and oncogenes in cancer.
In the search for new ways to better diagnose and monitor cancer, scientists have turned to oncogenes and tumor suppressor genes. These genes are involved in cell differentiation, communication and proliferation and their alteration is frequently associated with cancer. Such alterations include mutations, translocations, amplifications and deletions. In this review, I give examples of using the detection of such alterations for patient diagnosis and monitoring. The practical examples are restricted to a few cancer types, but the identification of new tumor suppressor genes, like BRCA-1 and BRCA-2, is creating new possibilities for determining cancer risk of individual family members. There is no doubt that the cloning of new genes which predispose to sporadic cancer will lead to the introduction of widespread testing to assess risk and to the application of preventive measures.
Diamandis
E P
EP
Department of Clinical Biochemistry, University of Toronto, Ontario, Canada.
D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D005784:Gene Amplification; D017353:Gene Deletion; D016147:Genes, Tumor Suppressor; D006801:Humans; D009369:Neoplasms / Q000235:genetics*; D009857:Oncogenes; D017354:Point Mutation; D014178:Translocation, Genetic
D016044:Fusion Proteins, bcr-abl